Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angie Veverka

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Vascular Health and Risk Management|December 15, 2007
Nebivolol in the treatment of chronic heart failureAngie Veverka, Jennifer L Salinas
Expert Review of Cardiovascular Therapy|October 27, 2004
Recent advances in the secondary prevention of coronary heart diseaseAngie Veverka, Jamie L Jolly
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 17, 2014
Improving pharmacist documentation of clinical interventions through focused educationKatherine B Rector, Angie Veverka, Stacie Krick Evans
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 8, 2011
Risk of cancer associated with the use of angiotensin II-receptor blockersJacqueline L Olin, Angie Veverka, Donald S Nuzum
Vascular Health and Risk Management|April 2, 2009
Long-acting nifedipine in the management of the hypertensive patientMorgan E Snider, Donald S Nuzum, Angie Veverka
The Annals of Pharmacotherapy|July 11, 2006
Nebivolol: a third-generation beta-adrenergic blockerAngie Veverka, Donald S Nuzum, Jamie L Jolly
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|January 18, 2008
Cardiovascular medication prescribing in older adults with psychiatric disordersChristian R Dolder, Angie Veverka, Donald S Nuzum, et al.
Pharmacotherapy|May 27, 2010
Urate-lowering therapy for gout: focus on febuxostatBryan L Love, Robert Barrons, Angie Veverka, et al.
Hospital Pharmacy|November 3, 2016
Incorporating a Pharmacist Into the Discharge Process: A Unit-Based Transitions of Care PilotHanlin Li, William Guffey, Laura Honeycutt, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Vascular Health and Risk Management|December 15, 2007
Nebivolol in the treatment of chronic heart failureAngie Veverka, Jennifer L Salinas
Expert Review of Cardiovascular Therapy|October 27, 2004
Recent advances in the secondary prevention of coronary heart diseaseAngie Veverka, Jamie L Jolly
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 17, 2014
Improving pharmacist documentation of clinical interventions through focused educationKatherine B Rector, Angie Veverka, Stacie Krick Evans
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 8, 2011
Risk of cancer associated with the use of angiotensin II-receptor blockersJacqueline L Olin, Angie Veverka, Donald S Nuzum
Vascular Health and Risk Management|April 2, 2009
Long-acting nifedipine in the management of the hypertensive patientMorgan E Snider, Donald S Nuzum, Angie Veverka
The Annals of Pharmacotherapy|July 11, 2006
Nebivolol: a third-generation beta-adrenergic blockerAngie Veverka, Donald S Nuzum, Jamie L Jolly
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|January 18, 2008
Cardiovascular medication prescribing in older adults with psychiatric disordersChristian R Dolder, Angie Veverka, Donald S Nuzum, et al.
Pharmacotherapy|May 27, 2010
Urate-lowering therapy for gout: focus on febuxostatBryan L Love, Robert Barrons, Angie Veverka, et al.
Hospital Pharmacy|November 3, 2016
Incorporating a Pharmacist Into the Discharge Process: A Unit-Based Transitions of Care PilotHanlin Li, William Guffey, Laura Honeycutt, et al.
Pageof 1